Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Babson Capital Corporate Investors

21.25
-0.2500-1.16%
Post-market: 21.250.00000.00%16:04 EDT
Volume:17.27K
Turnover:368.46K
Market Cap:431.35M
PE:12.19
High:21.52
Open:21.52
Low:20.80
Close:21.50
Loading ...
OverviewCompanyNewsFilings

SAGE Rejects Biogen's Offer to Buy Remaining Stake, Stock Up

Zacks
·
29 Jan

FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer's Disease in the US

PR Newswire
·
27 Jan

NFI’s MCI Secures Major Contract with Metrolinx

TIPRANKS
·
21 Jan

BRIEF-NFI Subsidiary MCI Awarded Five-Year Contract From Metrolinx

Reuters
·
21 Jan

Hosting sporting events in Singapore not just about 'economic receipts': SportSG chief

CNA
·
16 Jan

FDA accepts Biologics License Application for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US

PR Newswire
·
14 Jan

Biogen Offers to Buy Remaining Stake in Sage Therapeutics

Zacks
·
14 Jan

ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease

GlobeNewswire
·
10 Jan

Bank Tabungan Negara and Mandiri Capital Indonesia Establish Investment Cooperation to Encourage the Growth of the Housing Ecosystem

Tempo
·
08 Jan

Cities that rarely get snow are getting more than a foot in frigid 'arctic outbreak'

businessinsider.com
·
06 Jan

Analyst Rate

 
 
 
 

Corporate Actions

Ex-dividend Date
May 30, 2025 Dividend Per Share 0.4 USD
Ex-dividend Date
Dec 30, 2024 Dividend Per Share 0.5 USD
Financial Report Announcement
Nov 14, 2024
Ex-dividend Date
Nov 04, 2024 Dividend Per Share 0.4 USD
Ex-dividend Date
Aug 26, 2024 Dividend Per Share 0.4 USD

Dividend History

Ex-DateDividend
2015-07-300.3
2015-10-290.3
2015-12-290.3
2016-04-280.3
2016-07-280.3

Valuation Analysis

11.85
Current
14.03
Sector Average
69.27%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
11.85
Maximum
74.58
+1 STD
26.30
Minimum
5.00
-1 STD
1.76
Average
14.03

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.